| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +0.00% | +2.93% | +1.21% | +1.72% | +1.72% | — |
| 14d | 2 | +50.00% | +0.89% | +1.22% | -0.33% | -0.33% | — |
| 30d | 2 | +100.00% | -23.31% | +2.37% | -25.67% | -25.67% | — |
| 60d | 2 | +100.00% | -18.43% | -0.28% | -18.14% | -18.14% | — |
| 90d | 2 | +100.00% | -20.61% | -3.58% | -17.04% | -17.04% | — |
| 180d | 2 | +50.00% | -16.70% | +7.64% | -24.34% | -24.34% | — |
| 1y | 2(1 pending) | +100.00% | -37.20% | +17.20% | -54.40% | -54.40% | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| XLO XILIO THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 7,030 | $0.64 | $4.5K | 24,766 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE Chief Financial Officer | 19,375 | — | — | 38,750 | Jan 1, 2026 | Jan 5, 2026 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 19,375 | — | — | 31,796 | Jan 1, 2026 | Jan 5, 2026 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 668,789 | — | — | 668,789 | Dec 31, 2025 | Jan 5, 2026 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE Chief Financial Officer | 23,786 | — | — | 0 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE Chief Financial Officer | 37,296 | — | — | 0 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 23,786 | — | — | 23,786 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE Chief Financial Officer | 155,090 | — | — | 0 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE Chief Financial Officer | 20,000 | — | — | 0 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE Chief Financial Officer | 45,000 | — | — | 0 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 37,296 | — | — | 37,296 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 117,000 | — | — | 117,000 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALEGRANT Stock grant | 155,090 | — | — | 155,090 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 45,000 | — | — | 45,000 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE Chief Financial Officer | 117,000 | — | — | 0 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE Chief Financial Officer | 300,000 | — | — | 0 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 925,000 | — | — | 925,000 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE Chief Financial Officer | 150,000 | — | — | 0 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Apr 15, 2025 | Apr 16, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 6,954 | $0.98 | $6.8K | 12,421 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 251,000 | — | — | 251,000 | Jan 1, 2025 | Jan 3, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE Chief Financial Officer | 19,375 | — | — | 58,125 | Jan 1, 2025 | Jan 3, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 19,375 | — | — | 19,375 | Jan 1, 2025 | Jan 3, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 52,000 | — | — | 52,000 | Aug 3, 2024 | Aug 6, 2024 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 208,000 | — | — | 208,000 | May 1, 2024 | May 3, 2024 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 77,500 | — | — | 77,500 | Jan 1, 2024 | Jan 3, 2024 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Aug 16, 2023 | Aug 18, 2023 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Aug 3, 2023 | Aug 7, 2023 ↗ | View → |